244 / 464
244
POSTERS AND ELECTRONIC POSTERS
| Programme and Exhibition Guide
ELECTRONIC POSTERS
> Stereotactic robotic body radiotherapy for patients with pulmonary
oligometastases
P. Berkovic (Belgium), A. Gulyban, L. Swenen, D. Dechambre,
P. Viet Nguyen, N. Jansen, C. Mievis, N. Bartelemy, P. Lovinfosse,
M. Baré, F. Lakosi, L. Janvary, P.A. Coucke
EP-1226
> Neutrophil-lymphocyte ratio and a dosimetric factor for symptomatic
radiation pneumonitis in NSCLC
Y.H. Lee, H.S. Choi, H. Jeong, K.M. Kang (Republic of Korea), J.H. Song,
W.S. Lee, G.W. Lee, H.N. Song, H.G. Kim, M.H. Kang, D.Y. Rhee,
B.K. Jeong
EP-1227
> UK NCRI CTRad consensus on drug and radiotherapy combination
platform studies in NSCLC
G. Hanna (UK), F. McDonald, A. Greystoke, M. Forester, S. Brown,
E. Hall, C. Faivre-Finn, S. Harrow, M. Hatton, A. Chalmers
EP-1228
> Phase II trial of concurrent erlotinib in locally advanced non-small cell
lung cancer (LA-NSCLC)
O. Hansen (Denmark), M. Knap, A. Khalil, C. Nyhus, C. Brink,
L. Hoffmann, T. Schytte
EP-1229
> Post-operative radiotherapy (PORT) in patients with resected non small
cell lung cancer (NSCLC)
T. Schimek-Jasch (Germany), M. Kuppler, S. Adebahr, A.L. Grosu,
U. Nestle
EP-1230
> Early Clinical outcome of the first lung SBRT program in a developing
country
S. Wadi-Ramahi, J. Khader (Jordan), F. Abu Hijli, H. Ghatasheh,
A. Sulaiman
EP-1231
> Patient-reported toxicity in twice-daily (BID) versus once-daily (OD)
chemoradiotherapy for LS-SCLC
J. Lodeweges (The Netherlands), A. Niezink, H. Elzinga, E. Haan-Stijntjes,
N. Dollekamp, O. Chouvalova, J. Ubbels, M. Woltman-van Iersel,
A. Van der Leest, J. Langendijk, J. Widder
EP-1232
> Early results of SBRT as a salvage treatment after thoracic radiotherapy.
A. Navarro-Martin (Spain), I. Guix, J. Mases, M. Mutto, E. Nadal,
F. Guedea
EP-1233